Prognosis and long-term results of surgically treated aortic stenosis. 1988

B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
Department of Cardiology, Hôpital Tenon, Paris, France.

A total of 675 patients (mean age 60 +/- 11 years, range 22-85, 71% males) with calcified pure aortic stenosis (490) or mixed lesions (185) had an aortic prosthesis: 290 Starr-Edwards, 147 Bjork, 18 other mechanical valves, 163 pericardial xenografts, 57 porcine xenografts; 76 patients simultaneously underwent a coronary bypass, 12 a replacement of ascending aorta, and six a mitral valvuloplasty. Preoperatively, 67% were in functional class III or IV (NYHA); 69.5% had a coronary arteriography: significant coronary stenosis was observed in 27% of patients. The operative mortality was 6.8% depending on the functional class at surgery, age (4.9% before 70 years, vs. 12.5% after), and the date of surgery (8.1% before 1983 vs. 3.7% after). The 10- and 15-year actuarial survival rates were 62 +/- 3% and 44 +/- 4%, respectively. No significant differences were observed between patients with pure aortic stenosis and mixed aortic lesions. In patients over 70 years, the survival rates were 71 +/- 5% at five years and 51 +/- 10% at 10 years. Age, functional class, degree of congestive heart failure, and degree of cardiomegaly were the main preoperative predictors of late death. At 10 years, 88% of patients were free from myocardial dysfunction, 87% from thromboembolic events, and 89% from haemorrhages. We conclude that in this type of valvulopathy, short- and long-term surgical results are good despite the fact that most patients are elderly and in an advanced functional class.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011093 Polyethylene Terephthalates Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics. Dacron,Nalophan,PET Polymer,Poly(Ethylene Terephtalate),Polyethylene Terephthalate,Tedlar,Dacrons,Nalophans,PET Polymers,Tedlars,Terephthalate, Polyethylene,Terephthalates, Polyethylene
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002114 Calcinosis Pathologic deposition of calcium salts in tissues. Calcification, Pathologic,Calcinosis, Tumoral,Microcalcification,Microcalcinosis,Pathologic Calcification,Calcinoses,Calcinoses, Tumoral,Microcalcifications,Microcalcinoses,Tumoral Calcinoses,Tumoral Calcinosis
D005260 Female Females
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
December 1978, Archives des maladies du coeur et des vaisseaux,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
January 1996, Annales de chirurgie,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
July 1968, Annales de chirurgie thoracique et cardio-vasculaire,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
January 1985, Acta neurochirurgica,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
October 1997, Clinical neurology and neurosurgery,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
January 1995, Chirurgia (Bucharest, Romania : 1990),
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
April 1983, The Thoracic and cardiovascular surgeon,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
September 1959, Helvetica chirurgica acta,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
April 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
B Cormier, and P Luxereau, and C Bloch, and P Ducimetiere, and F Boustani, and G Badaoui, and P Dybantsa, and P Cheung, and G Preud'homme, and J Acar
December 1987, Helvetica chirurgica acta,
Copied contents to your clipboard!